Annual IMS meeting means back on socials! Dr. Moreau setting the tone with tremendous progress made over the past 3 decades and goals to achieve a cure (we're not far with improvements made in survival outcomes closing in on life expectancy of healthy ppl)!
#IMS25
@myeloma-society.bsky.social

Shonali Midha, MD, discusses how a new program to deliver bispecific T-cell engaging antibodies in the outpatient clinic has successfully reduced hospitalization for patients with multiple myeloma.
https://bit.ly/4igNN5W